Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model https://www.medrxiv.org/content/10.1101/2022.12.23.22283885
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.